Works matching IS 02724391 AND DT 2022 AND VI 83 AND IP 5

Results: 14

ZPI prevents ox‐LDL‐mediated endothelial injury leading to inhibition of EndMT, inflammation, apoptosis, and oxidative stress through activating Pi3k/Akt signal pathway.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1212, doi. 10.1002/ddr.21952

By:

Zhang, Xingxu;
Li, Zhiqiang;
Liu, Xiangdong;
Qin, Xiaoming;
Luo, Jiachen;
Zhang, Wenming;
Liu, Baoxin;
Wei, Yidong

Publication type:

Article

Phosphate moiety in FDA‐approved pharmaceutical salts and prodrugs.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1059, doi. 10.1002/ddr.21953

By:

Fulmali, Ameya;
Bharate, Sonali S.

Publication type:

Article

Chrysin promotes angiogenesis in rat hindlimb ischemia: Impact on PI3K/Akt/mTOR signaling pathway and autophagy.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1226, doi. 10.1002/ddr.21954

By:

Kamel, Rehab;
El Morsy, Engy M.;
Elsherbiny, Marwa E.;
Nour‐Eldin, Mahmoud

Publication type:

Article

Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1201, doi. 10.1002/ddr.21951

By:

Zhang, Meng;
Tao, Zhongyi;
Gao, Lijuan;
Chen, Fengyang;
Ye, Yiping;
Xu, Shifang;
Huang, Wenkang;
Li, Xiaoyu

Publication type:

Article

Xanthatin inhibits non‐small cell lung cancer proliferation by breaking the redox balance.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1176, doi. 10.1002/ddr.21941

By:

Xie, Yanbo;
Zhu, Xueyu;
Liu, Ping;
Liu, Yunxiao;
Geng, Yadi;
Zhang, Lei

Publication type:

Article

YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1190, doi. 10.1002/ddr.21942

By:

Wu, Min;
Chen, Guozhong;
Liao, Xiaowen;
Xiao, Lihua;
Zheng, Jianqing

Publication type:

Article

Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav‐1 signaling.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1167, doi. 10.1002/ddr.21940

By:

Chen, Jing;
Zhang, Huaming;
Yang, Yanbo;
Chen, Bo

Publication type:

Article

Secoisolariciresinol diglucoside induces pyroptosis by activating caspase‐1 to cleave GSDMD in colorectal cancer cells.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1152, doi. 10.1002/ddr.21939

By:

Chen, Tuo;
Wang, Zhen;
Zhong, Junbo;
Zhang, Lijun;
Zhang, Haopeng;
Zhang, Dayong;
Xu, Xiaofeng;
Zhong, Xianfei;
Wang, Jing;
Li, Hai

Publication type:

Article

Sophoraflavanone G suppresses the progression of triple‐negative breast cancer via the inactivation of EGFR–PI3K–AKT signaling.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1138, doi. 10.1002/ddr.21938

By:

Cheng, Wei;
Liu, Dan;
Guo, Min;
Li, Honglei;
Wang, Qiang

Publication type:

Article

Dendrobine modulates autophagy to alleviate ox‐LDL‐induced oxidative stress and senescence in HUVECs.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1125, doi. 10.1002/ddr.21937

By:

Lou, Danfei;
Xing, Xinyue;
Liang, Yunyu

Publication type:

Article

Shikonin attenuates kidney tubular epithelial cells apoptosis, oxidative stress, and inflammatory response through nicotinamide adenine dinucleotide phosphate oxidase 4/PTEN pathway in acute kidney injury of sepsis model.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1111, doi. 10.1002/ddr.21936

By:

Peng, Yanqin;
Li, Yuan;
Li, Hao;
Yu, Junhua

Publication type:

Article

Repurposing of digoxin in pain and inflammation: An evidence‐based study.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1097, doi. 10.1002/ddr.21935

By:

Patel, Saraswati;
Gururani, Ritika;
Jain, Smita;
Tripathi, Neetika;
Paliwal, Swati;
Paliwal, Sarvesh;
Paliwal, Shailendra;
Sharma, Swapnil

Publication type:

Article

New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF‐7 breast cancer cell line.

Published in:

Drug Development Research, 2022, v. 83, n. 5, p. 1075, doi. 10.1002/ddr.21934

By:

Sobh, Eman A.;
Khalil, Nadia A.;
Faggal, Samar I.;
Hassan, Marwa S. A.

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2022, v. 83, n. 5, p. 1057, doi. 10.1002/ddr.21827
Publication type:: Article